Navigation Links
Ranbaxy Receives Final Approval to Manufacture and Market Cetirizine Hydrochloride Oral Solution
Date:4/25/2008

Ohm Laboratories to Market in OTC Private Label Market

PRINCETON, N.J., April 25 /PRNewswire/ -- Ohm Laboratories Inc (Ohm), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today that RLL has received final approval from the U.S. Food and Drug Administration to manufacture and market Cetirizine Hydrochloride Oral Solution (Allergy) and Children's Cetirizine Hydrochloride Oral Solution (Hives-Relief), 1 mg/mL (OTC). The Office of Generic Drugs, U.S. Food and Drug Administration, has determined the Ohm formulation to be bioequivalent and have the same therapeutic effect as that of the reference listed drug Children's Zyrtec Oral Solution (Allergy) and Children's Zyrtec Oral Solution (Hives-Relief), 1mg/mL of McNeil Consumer Healthcare. Total annual market sales for Cetirizine Hydrochloride Syrup as a prescription only product were $157 million (IMS - MAT: December 2007).

Cetirizine Hydrochloride is indicated for the temporary relief of runny nose, sneezing, itching of the nose or throat, and itchy, watery eyes due to hay fever or other upper respiratory allergies. Other indications include relief from itching due to hives (urticaria).

"We are pleased to receive this final approval for Cetirizine Hydrochloride Oral Solution that has proven its clinical value and utility in both adults and children. We are pleased to offer this preferred formulation that will meet the needs of all patients who need this medication in response to allergic reactions as an over-the-counter product. This product formulation further expands our portfolio of affordable generic alternatives and will be launched immediately to all classes of trade participating in the OTC private label market," said Jim Meehan, Vice President of Sales and Distribution for Ohm Laboratories, a wholly owned subsidiary company of RLL.

Ohm, based in North Brunswick, New Jersey, is a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), Ind
'/>"/>

SOURCE Ranbaxy Laboratories Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Ranbaxy Gains Approval to Manufacture and Market Cefuroxime Axetil for Oral Suspension
2. Ranbaxy Receives Final Approval to Manufacture and Market Cetirizine Hydrochloride Tablets (OTC), 5mg and 10mg
3. Ranbaxy Receives Tentative Approval For Valsartan Tablets
4. Ranbaxy First to Gain Approval to Manufacture and Market Clarithromycin for Oral Suspension, USP
5. Ranbaxy Gains Approval to Manufacture and Market Carvedilol Tablets in the U.S. Market
6. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
7. Michael E. DeBakey Receives Congressional Gold Medal
8. Perrigo Receives FDA Approval to Market Orange, Coated Nicotine Gum
9. Cadient Group Receives Multiple Awards at 2008 DTC National Advertising Awards
10. The National Exercise & Sports Trainers Association Receives Accreditation of Its Personal Fitness Trainer Certification From the National Commission for Certifying Agencies (NCCA)
11. PainCare Receives Notices From American Stock Exchange
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... Rafael, CA (PRWEB) February 27, 2015 The ... provide campers with newer facilities and to make camp more ... a better location for a Contact Football Camp. The fields ... the best in the country,” states Mike de Surville, vice ... our staff is comprised of experienced coaches with the passion ...
(Date:2/27/2015)... February 27, 2015 RDI-Engineering will be ... Pi Day event on March 14, at Moreno Valley ... demonstrations on how to use engineering software and tools, ... be hosted by Moreno Valley College’s Upward Bound Math ... Center (SSC) in hopes to encourage students to seek ...
(Date:2/27/2015)... 27, 2015 Is it reasonable – and ... practices and games, and possible to do so without causing ... sports might be at high risk for concern and could ... the issues being addressed by two introductory bills, Int. ... hearing last month in New York City. More specifically, ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Many ... for people’s health. Mercola.com has introduced organic cotton ... contain toxic flame retardant chemicals. Dr. Mercola’s Healthy ... design and better materials. Organic cotton is significantly ... Mercola’s organic bedding products are made by Naturepedic ...
(Date:2/27/2015)... 2015 According to a Feb. 12, ... drug used to treat cancer by killing cancer stem cells, ... Drug Administration (FDA) for use in the treatment of mesothelioma.* ... the FDA to encourage the development of drugs for the ... about the FDA’s decision,” said Melinda Helbock, Founder of The ...
Breaking Medicine News(10 mins):Health News:US Sports Camps Football Camps Announce New Contact Football Camp Northeast Location 2Health News:RDI-Engineering Participates in STEM”U”LATE Your Mind Event to Host Educational Exhibition 2Health News:NYSATA Athletic Trainers Provide Expert Testimony at NYC Youth Concussion and Sports Safety Hearing 2Health News:NYSATA Athletic Trainers Provide Expert Testimony at NYC Youth Concussion and Sports Safety Hearing 3Health News:New Drug Receives FDA Approval as Orphan Drug for the Treatment of Mesothelioma 2Health News:New Drug Receives FDA Approval as Orphan Drug for the Treatment of Mesothelioma 3
... the deadly H5N1 strain of bird flu. Official sources, however, point ... spread of the virus is slow. , Nigeria, the ... reported any human cases, although experts warn that due to ineffective ... virus has now been reported in 14 of Nigeria's 36 states ...
... strides ahead with greater determination from obscurity to a global ... the pandemic// outpacing us, or are countries acting too slowly ... and affected another 40 million worldwide? ,In early ... the review meeting to the United Nations General Assembly's Special ...
... ITC Hotels on patisseries, Choco Fudge has been adjudged the ... ,The judges' panel consisted of eminent writers and fashion ... will take pride of place at all ITC hotels across ... ,Through the contest in Kolkata, ITC Hotels aims to ...
... the All India Institute of Medical Sciences has requested ... strict implementation of reservation// and end to 'victimisation' of ... ,Reacting to the gherao of the sub-dean of ... upon the President to exercise his moral authority and ...
... President of India wants the Government and people to ... and organ donation. In India., ,Inaugurating the blood ... Vice President asked the government and people to work in ... blood and organs must be encouraged to save precious lives, ...
... For severe COPD patients treated with budesonide added ... short acting bronchodilator, there is a reduced risk ... formoterol and/or terbutaline ,Important new data ... two pivotal Symbicort(R) studies, announced today at the ...
Cached Medicine News:Health News:AIDS: Why the pandemic outpaces us 2Health News:AIDS: Why the pandemic outpaces us 3Health News:Addition Of Budesonide To Formoterol Reduces Risk Of Mortality 2
(Date:2/26/2015)... MOUNTAIN VIEW, Calif. , Feb. 26, 2015  IRIDEX ... will release its fourth quarter and full year 2014 financial ... 2015.   In conjunction with the release, the Company will ... 5:00 p.m. Eastern Time on Thursday, March 5, ... other business developments. Interested parties may access the ...
(Date:2/26/2015)... 2015 Legislation passed today by the House ... help prevent inappropriate prescriptions in Medicare Part D from ... of Medicare Act (PIMA) of 2014 , introduced by ... (R-TX) and Ranking Member Jim McDermott (D-WA), recognizes ... and implement the right policies, said the Pharmaceutical Care ...
(Date:2/26/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/2vn6hh/radiation_therapy ) has ... - Global Strategic Business Report" report to their ... markets for Radiation Therapy Equipment in US$ Million by ... and Radiation Therapy Simulator. The report provides separate comprehensive ... Japan , Europe ...
Breaking Medicine Technology:IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date 2PCMA Statement on the 'Protecting the Integrity of Medicare Act' 2Radiation Therapy Equipment - Global Strategic Business Report 2015-2020: Linear Accelerator, Treatment Planning Systems, and Radiation Therapy Simulator 2
... Neurobiological Technologies, Inc. (Nasdaq: NTII ) ("NTI") announced ... dividend of $0.18 per share of common stock, which will ... as of November 30, 2009. The December 9, 2009 extraordinary ... to a plan of complete liquidation and dissolution and an ...
... , , WAYNE, Pa., Nov. 20 ... its fiscal first quarter ended September 30, 2009. ... decreased approximately $234,000, or 2.7%, to $8,435,000 during the three-month ... period last fiscal year. The Company reported the decreased ...
Cached Medicine Technology:Neurobiological Technologies Announces Extraordinary Dividend of $0.18 per Share 2Escalon(R) Reports First Quarter Fiscal 2010 Results 2Escalon(R) Reports First Quarter Fiscal 2010 Results 3Escalon(R) Reports First Quarter Fiscal 2010 Results 4Escalon(R) Reports First Quarter Fiscal 2010 Results 5Escalon(R) Reports First Quarter Fiscal 2010 Results 6Escalon(R) Reports First Quarter Fiscal 2010 Results 7
... Are Available In Two Models: One Is Direct ... Jaws Close. The Other Model Is Reverse ... Compressed The Jaws Open., ,The Forceps Are 22g, ... Through A 1.1mm Incision. These Forceps Allow The ...
... Allows Use Through A 1-Millimeter Incision.,Special ... Approach To The Incision.,Cystotome Tips Are ... Initiate And Complete A Circular Tear.,Titanium ... Improved Ergonomic Feel. Ideal For Bi-Manual ...
... fiber optic for homogenous illumination. ... bright halogen illumination for clear ... canal. Lithium-ion batteries with ... rheostat for fine control of ...
All Keeler otoscopes have bright halogen illumination for clear and accurate visualization of aural canal. Lithium-ion batteries with quick recharge capability. Ring rheostat for fine control of il...
Medicine Products: